Skip to main content
COWEALTH MEDICAL CHINA CO.,LTD. logo

COWEALTH MEDICAL CHINA CO.,LTD. — Investor Relations & Filings

Ticker · 603122 ISIN · CNE100005R39 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 420 across all filing types
Latest filing 2026-03-13 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603122

About COWEALTH MEDICAL CHINA CO.,LTD.

https://ch.cowealth.com/en/index.html

Cowealth Medical China Co., Ltd. specializes in providing comprehensive supply chain management services for the healthcare sector. The company focuses on the distribution and integrated logistics of medical devices, laboratory reagents, and high-value consumables. Its core service model includes Supply, Processing, and Distribution (SPD) solutions, which streamline hospital inventory management and procurement processes through advanced information technology. By acting as a centralized platform, the company connects global medical equipment manufacturers with healthcare institutions, ensuring the efficient delivery and maintenance of clinical supplies. Its operations emphasize operational efficiency, cost reduction for medical facilities, and the implementation of standardized quality control systems across the medical supply chain.

Recent filings

Filing Released Lang Actions
关于合富（中国）医疗科技股价有限公司2025年度非经营性资金占用及其他关联资金往来情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a special explanatory statement regarding non-operating fund occupation and other related party fund transactions for the year 2025 of 合富 (中国) 医疗科技股份有限公司. It includes an audit report issued by KPMG Huazhen LLP with a standard unqualified opinion on the 2025 financial statements. The document references regulatory guidelines from Chinese securities and banking authorities and includes detailed tables summarizing related party transactions and non-operating fund usage. The content is focused on a specific audit-related disclosure and detailed financial data about related party transactions, not a full annual report or interim report. It is a standalone audit-related report explaining a specific aspect of the company's financials, consistent with an Audit Report / Information filing rather than a full Annual Report or other categories. The document length (12,541 characters) and detailed financial tables confirm it is a substantive report, not merely an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2025
2026-03-13 Chinese
合富中国关于2025年度会计师事务所的履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is an evaluation report on the performance of the accounting firm KPMG Huazhen for the fiscal year 2025. It details the qualifications, audit quality, management, and compliance of the auditor in relation to the company's 2025 annual audit. The document does not contain financial statements or direct financial data but rather an assessment of the auditor's work and quality control. This type of document is a standalone audit-related report focusing on the auditor's performance and compliance, which fits the definition of an Audit Report / Information (AR). The document length is 3029 characters, which is sufficient to be a report rather than a brief announcement. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-03-13 Chinese
合富中国2025年年度审计报告
Annual Report Classification · 97% confidence The document is titled “2025 年年度报告” (2025 Annual Report) of 合富 (中国) 医疗科技股份有限公司 and contains the full audited financial statements (consolidated balance sheet, income statement, cash flows, statements of changes in equity, and notes) as well as the auditor’s report and key audit matters. It is a comprehensive year‐end report covering the company’s financial performance and position, fitting the definition of an Annual Report. FY 2025
2026-03-13 Chinese
合富中国董事会审计委员会对会计师事务所2025年度履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee regarding the performance and supervision of the external audit firm (KPMG Huazhen) for the fiscal year 2025. It discusses the audit firm's qualifications, the audit process, communication with management, and the audit committee's evaluation of the audit firm's work. The document includes references to the audit of the 2025 financial statements and internal controls, the issuance of audit reports, and the audit committee's oversight role. It is not the audit report itself but a supervisory report on the audit firm's performance and the audit process. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and information about audit processes and results of internal controls, excluding the full annual report. The document length is 1913 characters, which is relatively short but contains substantive content about the audit firm's duties and oversight, not merely an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-03-13 Chinese
合富中国2025年内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2025 by 合富（中国）医疗科技股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2025, including financial and non-financial internal control defects, their identification standards, and remediation status. The content is detailed and specific to internal control evaluation rather than a general annual report or audit report. It does not appear to be a full annual report (10-K) or audit report (AR) but rather a specialized internal control evaluation report. Given the definitions, this document fits best under Audit Report / Information (AR) as it is a standalone report on internal control evaluation and audit-related findings, excluding a full annual report. The document length is 4580 characters, which is sufficient for a detailed report rather than a brief announcement or certification. Therefore, the classification is AR with high confidence. FY 2025
2026-03-13 Chinese
关于合富(中国)医疗科技股份有限公司2025年度营业收入扣除情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a special explanation regarding the deduction of operating income for the fiscal year 2025 of 合富 (中国) 医疗科技股份有限公司. It is prepared by KPMG Huazhen LLP, an independent auditor, and references the audited financial statements for the year ending December 31, 2025. The document includes an audit opinion and reconciliation of amounts with the audited financial statements. It is not the full annual report but a standalone audit-related explanation focusing on a specific financial aspect (operating income deduction). The document length is 1435 characters, which is short but contains substantive audit content rather than just an announcement or certification. Therefore, it fits best under Audit Report / Information (AR) rather than Annual Report (10-K) or Report Publication Announcement (RPA). FY 2025
2026-03-13 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.